HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations
Italia Falcone(Istituti di Ricovero e Cura a Carattere Scientifico), Michèle Milella(National Cancer Institute)
Cited by 0
Related Papers
PTEN: Multiple Functions in Human Malignant Tumors
|Frontiers in Oncology|2015|460
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
|Blood|2006|42
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View
|Pharmaceuticals|2025|10